0H8T Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Aclaris Therapeutics Inc

Watchlist Manager

Watchlist

Price: 5.21 USD -1.7% Market Closed

Market Cap: $564.5m

	Aclaris Therapeutics Inc LSE:0H8T	US
K	Kurita Water Industries Ltd F:KWI	JP
D	Derichebourg SA XBER:PNU	FR
A	AUTO1 Group SE XHAN:AG1	DE

Profitability Summary

Aclaris Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

10%

Sustainable 3Y Average Gross Margin

28%

Declining Gross Margin

58% > 10%

Negative Operating Margin

-962%

Negative 3Y Average Operating Margin

-556%

Declining Operating Margin

-336% > -962%

Negative Net Margin

-833%

Negative 3Y Average Net Margin

-544%

Declining Net Margin

-338% > -833%

Negative Free Cash Flow Margin

-625%

Negative 3Y Average Free Cash Flow Margin

-336%

Declining Free Cash Flow Margin

-241% > -625%

Negative ROE

-48%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-157%

ROIC is Increasing

-163% > -98%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.